Promising Results of Personalized Cancer Vaccin...

By Rene Pretorius

February 10, 2025

A phase I clinical trial evaluating a personalized cancer vaccine has demonstrated promising outcomes for patients with high-risk, fully resected clear cell
Cost-Effective CML Treatment in South Africa
Trends in Endometrial Cancer Mortality
Boosting HPV Vaccine Uptake Among Young People Post-Pandemic
Cervical Cancer Burden: Global Trends and Future Projections
FDA Grants Datopotamab Deruxtecan Approval for HR-Positive Breast Cancer Trea...
MPA Meningioma Risk: Key Insights and Implications
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
Promising Dual Immunotherapy for Anaplastic Thyroid Cancer
Valuable, Cost-Effective Thyroid Cancer Diagnosis
WHO Prequalifies First G6PD Diagnostic Test